Understanding the complexities of Parkinson's Disease (PD) is crucial for healthcare professionals. As the second most common neurodegenerative disorder, it presents unique challenges in diagnosis and management.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to a disruption in the balance of dopamine and acetylcholine. This imbalance results in the cardinal motor symptoms of PD: bradykinesia, tremor, rigidity, and postural instability.
Motor symptoms are often the initial presentation, but non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are common. As the disease progresses, motor symptoms may become more prominent and disabling.
Diagnosis is primarily clinical, based on history and physical examination. Neuroimaging, while not routinely used, can support the diagnosis in uncertain cases. Biomarkers are an area of active research but are not currently used in clinical practice.
Treatment is symptomatic and includes pharmacological and non-pharmacological interventions. Levodopa remains the most effective medication for motor symptoms. Non-pharmacological interventions include physical therapy, occupational therapy, and speech therapy.
PD is a progressive disease with variable rates of progression. Factors influencing prognosis include age at onset, severity of symptoms, and presence of comorbidities. While there is currently no cure, treatments can significantly improve quality of life.
In conclusion, PD is a complex neurodegenerative disorder requiring a comprehensive approach to diagnosis and management. As healthcare professionals, it is essential to stay abreast of the latest research and treatment options to provide the best care for our patients.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation